BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Part of paid clinical trials in Sacramento, California.
- Sponsor
- Leigh R. Hochberg, MD, PhD.
- Study ID
- NCT00912041
- Status
- Recruiting
Conditions
- Amyotrophic Lateral Sclerosis
- Brain Stem Infarctions
- Locked in Syndrome
- Muscular Dystrophy
- Spinal Cord Injuries
- Tetraplegia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Placement of the BrainGate2 sensor(s) into the motor-related cortex — DEVICEUp to six 4x4 mm BrainGate2 sensor(s) are placed into the motor-related cortex (including speech-related areas of cortex), connected to one, two, or three percutaneous pedestals. Neural recordings are made at least weekly for a year or more.
Study Details
The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
Key Dates
- Start date
- May 31, 2009
- Status verified
- May 2026
- Primary completion
- Sep 30, 2038
- Completion
- Dec 31, 2038
Study Design
- Enrollment
- 27 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Other: BrainGateBrainGate Neural Interface System
Primary Outcome Measure
The primary endpoint of this Study is to determine the safety of the BrainGate2 Neural Interface System. [ Time Frame: One year post-implant evaluation period ]
Central Contacts
- Leigh R Hochberg, M.D., Ph.D.617-724-9247
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, Davis | Sacramento | California | 95817 | David M Brandman, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Stanford University School of Medicine | Stanford | California | 94305 | Jaimie Henderson, M.D. (PRINCIPAL_INVESTIGATOR) |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | Nicholas Au Yong, M.D., Ph.D. (PRINCIPAL_INVESTIGATOR) |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Leigh R Hochberg, M.D., Ph.D. (PRINCIPAL_INVESTIGATOR) Sydney S Cash, M.D., Ph.D. (SUB_INVESTIGATOR) Ziv Williams, M.D., Ph.D. (SUB_INVESTIGATOR) |
| Providence VA Medical Center | Providence | Rhode Island | 02908 | Stephen Mernoff, M.D. Stephen Mernoff, M.D. (PRINCIPAL_INVESTIGATOR) Leigh R Hochberg, M.D., Ph.D. (SUB_INVESTIGATOR) |
| Baylor College of Medicine | Houston | Texas | 77030 | Sameer Sheth, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Sacramento, CA
Related Studies
- The National Amyotrophic Lateral Sclerosis RegistryRecruiting · Centers for Disease Control and Prevention · Atlanta, Georgia
- Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal InjuryRecruiting · Spaulding Rehabilitation Hospital · Cambridge, Massachusetts
- Phenotype, Genotype & Biomarkers in ALS and Related DisordersEnrolling By Invitation · University of Miami · Palo Alto, California
- Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS PatientsPHASE3 · Recruiting · AB Science · Birmingham, Alabama